Cargando…
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease
The SARS-CoV-2 main protease (M(pro)) is one of the molecular targets for drug design. Effective vaccines have been identified as a long-term solution but the rate at which they are being administered is slow in several countries, and mutations of SARS-CoV-2 could render them less effective. Moreove...
Autores principales: | Fadaka, Adewale Oluwaseun, Sibuyi, Nicole Remaliah Samantha, Martin, Darius Riziki, Klein, Ashwil, Madiehe, Abram, Meyer, Mervin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430653/ https://www.ncbi.nlm.nih.gov/pubmed/34502340 http://dx.doi.org/10.3390/ijms22179431 |
Ejemplares similares
-
Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus
por: Fadaka, Adewale Oluwaseun, et al.
Publicado: (2021) -
Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer
por: Fadaka, Adewale Oluwaseun, et al.
Publicado: (2021) -
MicroRNA-based regulation of Aurora A kinase in breast cancer
por: Fadaka, Adewale Oluwaseun, et al.
Publicado: (2020) -
Nanotechnology-Based Delivery Systems for Antimicrobial Peptides
por: Fadaka, Adewale Oluwaseun, et al.
Publicado: (2021) -
Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care
por: Martin, Darius Riziki, et al.
Publicado: (2021)